Press Releases
- ORAL LAQUINIMOD FOR MULTIPLE SCLEROSIS TREATMENT SIGNIFICANTLY REDUCED DISEASE ACTIVITY AND DISABILITY PROGRESSION WHILE PROVIDING GOOD SAFETY AND TOLERABILITY April 12, 2011 07:37 (CEST)
- Teva Announces Webcast on Results from Phase III ALLEGRO Study of Oral Laquinimod in Multiple Sclerosis April 11, 2011 08:30 (CEST)
- Annual Report 2010 Active Biotech AB (publ) April 6, 2011 10:00 (CEST)
- Notice of Annual General Meeting of Shareholders April 5, 2011 08:30 (CEST)
- Helén Tuvesson appointed as new Chief Scientific Officer at Active Biotech March 15, 2011 15:00 (CET)
- Number of shares and votes in Active Biotech February 28, 2011 10:30 (CET)
- Active Biotech's TASQ prostate cancer project presented at 2011 Genitourinary Cancers Symposium February 18, 2011 08:30 (CET)
- Active Biotech AB Year-end Report January - December 2010 February 10, 2011 08:30 (CET)
- Active Biotech successfully completes private placement of SEK 375 million January 27, 2011 08:00 (CET)
- Active Biotech announces launch of private placement of new shares January 26, 2011 18:00 (CET)